Brief: Lumega-Z® Demonstrates Superiority In A Study Showing Better Bioavailability Of Carotenoids And Restoring Macular Pigment Density
May 12 (Reuters) - Guardion Health Sciences Inc GHSI.O :
* LUMEGA-Z® DEMONSTRATES SUPERIORITY IN A HEAD-TO-HEAD STUDY
SHOWING BETTER BIOAVAILABILITY OF CAROTENOIDS AND RESTORING
MACULAR PIGMENT DENSITY
* GUARDION HEALTH - RESULTS DEMONSTRATED THAT HIGHER
CONCENTRATION
OF CAROTENOIDS TRANSLATES TO A GREATER ELEVATION OF CAROTENOIDS
IN TARGET TISSUES
* GUARDION HEALTH SCIENCES INC - LUMEGA-Z SUPPLEMENTATION
PROVIDES
APPROXIMATELY 3-4-FOLD HIGHER ABSORPTION THAN STANDARD AREDS 2
FORMULATION
Source text for Eikon: ID:nGNX8LYPw6
Further company coverage: GHSI.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Guardion Health Sciences
See all newsBrief: Guardion Health Sciences Announces Termination Of CEO, Effective October 17
Brief: Guardion Health Sciences Announces Completion Of Sale Of Its Viactiv® Brand And Business To Doctor’S Best Inc. And Stockholder Approval Of Plan Of Liquidation And Dissolution
Brief: Guardion Health Sciences Announces Its Largest Stockholder Has Voted In Favor Of Proposals To Sell The Viactiv Business
Guardion Health Sciences Inc reports results for the quarter ended in March - Earnings Summary
Guardion Health Sciences Inc expected to post a loss of 88 cents a share - Earnings Preview